Artwork
iconShare
 
Manage episode 454778177 series 2965877
Content provided by IQT. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IQT or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Welcome to another episode of IQT Explains! In Part 2 of our Biotech and Investments series, we continue to explore IQT's cutting-edge work in biotechnology, focusing on our more recent investment activity and breaking down the latest developments in this ever-evolving domain. Our guests, Eugene Chiu and Dr. Michelle Rozo, delve into IQT's unique architectural approach, advancements in mRNA vaccines, gene editing, and AI-enabled biotech, as well as the challenges and opportunities ahead.

Tune in for an insightful discussion on the current biotech landscape and its impact on national security.

Key Topics

- Global Competition and U.S. Response

- Latest Developments and Innovations

- Challenges and Opportunities Ahead

- Geopolitical Influence

- Future Prospects and Potential Risks

Featured in this Episode

Farid Nemri

Program Manager

LinkedIn: https://www.linkedin.com/in/faridnemri/

Eugene Chiu

Senior Partner, Investments

LinkedIn - https://www.linkedin.com/in/eugenechiu

Dr. Michelle Rozo

VP Technology

LinkedIn - https://www.linkedin.com/in/michelle-rozo

  continue reading

86 episodes